These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31737407)

  • 1. Antenatal Magnesium Sulfate Exposure and Hemodynamically Significant Patent Ductus Arteriosus in Premature Infants.
    Qasim A; Jain SK; Aly AM
    AJP Rep; 2019 Oct; 9(4):e353-e356. PubMed ID: 31737407
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus.
    Harris SL; More K; Dixon B; Troughton R; Pemberton C; Horwood J; Ellis N; Austin N
    Eur J Pediatr; 2018 Apr; 177(4):521-532. PubMed ID: 29352349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal pro-brain natriuretic peptide used for screening hemodynamically significant patent ductus arteriosus in very low birth weight infants: How and when?
    Liu Y; Huang ZL; Gong L; Zhang Z; Zhang SC; Zhou YX
    Clin Hemorheol Microcirc; 2020; 75(3):335-347. PubMed ID: 32280084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates.
    Sanjeev S; Pettersen M; Lua J; Thomas R; Shankaran S; L'Ecuyer T
    J Perinatol; 2005 Nov; 25(11):709-13. PubMed ID: 16222347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antenatal exposure to magnesium sulfate and the incidence of patent ductus arteriosus in extremely low birth weight infants.
    del moral T; Gonzalez-Quintero VH; Claure N; Vanbuskirk S; Bancalari E
    J Perinatol; 2007 Mar; 27(3):154-7. PubMed ID: 17314984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-type and N-terminal pro-B-type natriuretic peptides are equally useful in assessing patent ductus arteriosus in very preterm infants.
    König K; Guy KJ; Drew SM; Barfield CP
    Acta Paediatr; 2015 Apr; 104(4):e139-42. PubMed ID: 25488470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NT-proBNP Levels Improve the Ability of Predicting a Hemodynamically Significant Patent Ductus Arteriosus in Very Low-Birth-Weight Infants.
    Buddhe S; Dhuper S; Kim R; Weichbrod L; Mahdi E; Shah N; Kona S; Sokal M
    J Clin Neonatol; 2012 Apr; 1(2):82-6. PubMed ID: 24027696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-sensitivity troponin T in preterm infants with a hemodynamically significant patent ductus arteriosus.
    Asrani P; Aly AM; Jiwani AK; Niebuhr BR; Christenson RH; Jain SK
    J Perinatol; 2018 Nov; 38(11):1483-1489. PubMed ID: 30171214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can early B-type natriuretic peptide assays predict symptomatic patent ductus arteriosus in extremely low birth weight infants?
    Lee JH; Shin JH; Park KH; Rhie YJ; Park MS; Choi BM
    Neonatology; 2013; 103(2):118-22. PubMed ID: 23182972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus.
    Farombi-Oghuvbu I; Matthews T; Mayne PD; Guerin H; Corcoran JD
    Arch Dis Child Fetal Neonatal Ed; 2008 Jul; 93(4):F257-60. PubMed ID: 18218660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-type natriuretic Peptide assay for the diagnosis and prognosis of patent ductus arteriosus in preterm infants.
    Kim JS; Shim EJ
    Korean Circ J; 2012 Mar; 42(3):192-6. PubMed ID: 22493614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical characteristics and cardiac hemodynamic changes of patent ductus ateriosus in preterm infants].
    Lu D; Liu Y; Tong X
    Zhonghua Er Ke Za Zhi; 2015 Mar; 53(3):187-93. PubMed ID: 26165015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants.
    Nuntnarumit P; Khositseth A; Thanomsingh P
    J Perinatol; 2009 Feb; 29(2):137-42. PubMed ID: 19020527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminant Analysis of Main Prognostic Factors Associated with Hemodynamically Significant PDA: Apgar Score, Silverman-Anderson Score, and NT-Pro-BNP Level.
    Permyakova AV; Porodikov A; Kuchumov AG; Biyanov A; Arutunyan V; Furman EG; Sinelnkov YS
    J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34442025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter closure of hemodynamic significant patent ductus arteriosus in 32 premature infants by amplatzer ductal occluder additional size-ADOIIAS.
    Morville P; Akhavi A
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):612-617. PubMed ID: 28471089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfusion Index-Bedside Diagnosis of Hemodynamically Significant Patent Ductus Arteriosus.
    Balla KC; John V; Rao Pn S; Varghese K
    J Trop Pediatr; 2016 Aug; 62(4):263-8. PubMed ID: 26966242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patent ductus arteriosus in preterm infants born at 23-24 weeks' gestation: Should we pay more attention?
    Dani C; Mosca F; Cresi F; Lago P; Lista G; Laforgia N; Del Vecchio A; Corvaglia L; Paolillo P; Trevisanuto D; Capasso L; Fanos V; Maffei G; Boni L
    Early Hum Dev; 2019 Aug; 135():16-22. PubMed ID: 31212222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late Acetaminophen Therapy for Patent Ductus Arteriosus in the Preterm Neonate.
    King R; Colon M; Stanfel L; Tauber KA
    J Pediatr Pharmacol Ther; 2020; 25(6):507-513. PubMed ID: 32839654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal calcium channel blocker exposure and subsequent patent ductus arteriosus in extremely low-birth-weight infants.
    McGuirl J; Arzuaga B; Lee BH
    Pediatr Cardiol; 2012 Jan; 33(1):60-4. PubMed ID: 21861146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early N-Terminal Pro B-Type Natriuretic Peptide (NTproBNP) Plasma Values and Associations with Patent Ductus Arteriosus Closure and Treatment-An Echocardiography Study of Extremely Preterm Infants.
    Gudmundsdottir A; Bartocci M; Picard O; Ekström J; Chakhunashvili A; Bohlin K; Attner C; Printz G; Karlsson M; Mohlkert LA; Karlén J; Pegelow Halvorsen C; Edstedt Bonamy AK
    J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.